- Home
- RSLS vs LIPO Comparison
RSLS vs LIPO Comparison
Compare RSLS & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- LIPO
- Stock Information
- Founded
- RSLS 2002
- LIPO 2005
- Country
- RSLS United States
- LIPO United States
- Employees
- RSLS N/A
- LIPO N/A
- Industry
- RSLS Medical/Dental Instruments
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- RSLS Health Care
- LIPO Health Care
- Exchange
- RSLS Nasdaq
- LIPO Nasdaq
- Market Cap
- RSLS 3.1M
- LIPO 3.5M
- IPO Year
- RSLS 2007
- LIPO 2022
- Fundamental
- Price
- RSLS $4.38
- LIPO $2.61
- Analyst Decision
- RSLS Hold
- LIPO Strong Buy
- Analyst Count
- RSLS 1
- LIPO 1
- Target Price
- RSLS N/A
- LIPO $16.00
- AVG Volume (30 Days)
- RSLS 30.3K
- LIPO 162.9K
- Earning Date
- RSLS 11-14-2024
- LIPO 11-14-2024
- Dividend Yield
- RSLS N/A
- LIPO N/A
- EPS Growth
- RSLS N/A
- LIPO N/A
- EPS
- RSLS N/A
- LIPO N/A
- Revenue
- RSLS $8,183,000.00
- LIPO $483,533.00
- Revenue This Year
- RSLS $17.47
- LIPO N/A
- Revenue Next Year
- RSLS $20.00
- LIPO N/A
- P/E Ratio
- RSLS N/A
- LIPO N/A
- Revenue Growth
- RSLS N/A
- LIPO 0.78
- 52 Week Low
- RSLS $4.09
- LIPO $2.21
- 52 Week High
- RSLS $29.00
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- RSLS 32.94
- LIPO 44.68
- Support Level
- RSLS $4.09
- LIPO $2.53
- Resistance Level
- RSLS $4.80
- LIPO $2.78
- Average True Range (ATR)
- RSLS 0.40
- LIPO 0.27
- MACD
- RSLS -0.06
- LIPO -0.02
- Stochastic Oscillator
- RSLS 18.24
- LIPO 7.77
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.